Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel method for the preparation of highly active immobilized enzymes is described. It is based on the binding of enzymes to suitable carriers via monoclonal antibodies, which bind to the enzyme with high affinity without affecting its catalytic activity. The applicability of the method forwarded has been illustrated by the preparation of two samples of highly active immobilized
carboxypeptidase A
(
CPA
) preparations as follows: A mouse monoclonal antibody (mAb 100)to
CPA
that binds to the enzyme with a high-affinity constant without affecting its catalytic activity was prepared, purified, and characterized. Covalent binding of this monoclonal antibody to Eupergit C (EC) or noncovalent binding to Sepharose-protein A (SPA)yielded the conjugated carriers EC-mAb and SPA.mAb, respectively, which reacted specifically with
CPA
to give the immobilized enzyme preparations EC-mAb.
CPA
and SPA.mAb.
CPA
displaying full catalytic activity and improved stability. At pH 7.5 and a temperature range of 4-37 degrees C an apparent binding constant of approximately 10(8)M(-1) characterizing the interaction of
CPA
with EC-mAb and SPA.mAb, was obtained. To compare the properties of EC-mAb.
CPA
and SPA.mAb.
CPA
with those of immobilized
CPA
preparations obtained by some representative techniques of covalent binding of the enzyme with a corresponding carrier, the following immobilized
CPA
preparations were obtained and their properties investigated: EC-
CPA
(I), a preparation obtained by direct binding of EC with
CPA
; EC-NH-GA-
CPA
(II), a derivative obtained by covalent binding of
CPA
to aminated EC via glutaraldehyde; EC-NH-Su-
CPA
(III), a
CPA
derivative obtained by binding the enzyme to aminated EC via a succinyl residue; and EC-
HMD
-GA-
CPA
(IV), obtained by binding the enzyme via glutaraldehyde to a hexamethylene diamine derivative of EC. Full enzymic activity for all of the bound enzyme, such as that recorded for the immobilized
CPA
preparations EC-mAb.
CPA
and SPA.mAb.
CPA
, was not detected in any of the insoluble covalently bound enzyme preparations.
...
PMID:Enzyme immobilization via monoclonal antibodies I. Preparation of a highly active immobilized carboxypeptidase A. 1855 48